Prosecution Insights
Last updated: May 29, 2026
Application No. 17/623,865

BLOOD TESTING DEVICE

Non-Final OA §102§112
Filed
Dec 29, 2021
Priority
Jul 09, 2019 — LU LU101301 +1 more
Examiner
WINAKUR, ERIC FRANK
Art Unit
3791
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Hemovent GmbH
OA Round
3 (Non-Final)
79%
Grant Probability
Favorable
3-4
OA Rounds
0m
Est. Remaining
93%
With Interview

Examiner Intelligence

Grants 79% — above average
79%
Career Allowance Rate
818 granted / 1036 resolved
+9.0% vs TC avg
Moderate +14% lift
Without
With
+14.0%
Interview Lift
resolved cases with interview
Typical timeline
3y 2m
Avg Prosecution
25 currently pending
Career history
1065
Total Applications
across all art units

Statute-Specific Performance

§101
2.3%
-37.7% vs TC avg
§103
46.9%
+6.9% vs TC avg
§102
13.1%
-26.9% vs TC avg
§112
10.3%
-29.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1036 resolved cases

Office Action

§102 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on July 8, 2025 has been entered. Claim Interpretation The following is a quotation of 35 U.S.C. 112(f): (f) Element in Claim for a Combination. – An element in a claim for a combination may be expressed as a means or step for performing a specified function without the recital of structure, material, or acts in support thereof, and such claim shall be construed to cover the corresponding structure, material, or acts described in the specification and equivalents thereof. The following is a quotation of pre-AIA 35 U.S.C. 112, sixth paragraph: An element in a claim for a combination may be expressed as a means or step for performing a specified function without the recital of structure, material, or acts in support thereof, and such claim shall be construed to cover the corresponding structure, material, or acts described in the specification and equivalents thereof. This application includes one or more claim limitations that do not use the word “means,” but are nonetheless being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, because the claim limitation(s) uses a generic placeholder that is coupled with functional language without reciting sufficient structure to perform the recited function and the generic placeholder is not preceded by a structural modifier. Such claim limitation(s) is/are: “throughflow unit” in claims 15, 29, and 30 (referred to, but not a positively claimed element in each of these claim sets) and claim 25. Because this/these claim limitation(s) is/are being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, it/they is/are being interpreted to cover the corresponding structure described in the specification as performing the claimed function, and equivalents thereof. If applicant does not intend to have this/these limitation(s) interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, applicant may: (1) amend the claim limitation(s) to avoid it/them being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph (e.g., by reciting sufficient structure to perform the claimed function); or (2) present a sufficient showing that the claim limitation(s) recite(s) sufficient structure to perform the claimed function so as to avoid it/them being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. Claim Rejections - 35 USC § 112 The following is a quotation of the first paragraph of 35 U.S.C. 112(a): (a) IN GENERAL.—The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor or joint inventor of carrying out the invention. The following is a quotation of the first paragraph of pre-AIA 35 U.S.C. 112: The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor of carrying out his invention. Claims 25 – 27 are rejected under 35 U.S.C. 112(a) or pre-AIA 35 U.S.C. 112, first paragraph, because the claim purports to invoke 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, but fails to recite a combination of elements as required by that statutory provision and thus cannot rely on the specification to provide the structure, material or acts to support the claimed function. As such, the claim recites a function that has no limits and covers every conceivable means for achieving the stated function, while the specification discloses at most only those means known to the inventor. Accordingly, the disclosure is not commensurate with the scope of the claim. In particular, the “throughflow unit” is the only claimed element of the system. The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 15 – 18, 20 – 27, 29, and 30 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. With regard to claim 15, the claim is directed to a “handheld blood testing device” wherein the only positively claimed element is a “housing”. While one could understand and assess whether a housing includes the claimed dimensions and weights, one of ordinary skill in the art would not recognize the property of “operated without cables” as being generally associated with a housing. As such, it is unclear how the limitation is intended to limit the positively claimed structure. In addition, the preamble of the claim refers to certain intended uses of the device (“direct connection to”, “recording of blood parameters”) but there do not appear to be claimed elements associated with these details. Claims 29 and 30 include parallel limitations to those of claim 15 and are rejected accordingly. With regard to claim 17, the claim refers to properties that are not readily associated with the positively claimed housing element of the claimed invention. Further, it is unclear how an autonomous measuring/processing element (if positively claimed) could operate without connection to a power supply, as the language appears to require. With regard to claims 20 - 22, it appears that the claims are directed to elements associated with the “throughflow unit”; however, claim 15, as currently set forth does not positively claim such an element, and therefore the claims do not appear to relate to any positively claimed element of the “blood testing device” itself. With regard to claim 24, the claim refers to properties that are not readily associated with the positively claimed housing element of the claimed invention (the only claimed structure). As such, the metes and bound of the claim limitation cannot be readily resolved. With regard to claim 25, the claim sets forth a system comprising a “throughflow unit” and indicates it is designed to be coupled to a blood testing device and also “the throughflow unit having a blood testing device according to claim 15”; however, the structure of claim 15 is claimed to be distinct from, but connectable to such a unit, consistent with the first aspect set forth in claim 25. It is unclear how the structure of claim 15, in context of claim 25, can satisfy both the requirements set forth therein and the details of claim 25 which are contrary thereto. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 15 – 24, 29, and 30 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Isaacson et al. (USPN 5,490,523). Isaacson et al. teach a clip sensor (Figures 5 – 7, 14) having a housing with dimensions (column 3, lines 41 – 45) consistent with the claim requirements. The clip includes emitter, detector, and processing elements, as well as indicator LEDs (column 5, lines 16 – 30) to display information to a user and batteries for supplying power. A communication interface permits connection to remote devices. Consistent with the details of the rejection set forth under 35 USC 112(b) above, one of ordinary skill in the art would recognize Isaacson et al. as meeting all positively claimed elements. Claim(s) 25 - 27 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Steuer et al. (USPN 5,351,686). Steuer et al. teach a disposable cuvette/throughflow unit (Figures 2, 4, 6, 8 and the descriptions thereof) for connection to tubing of a dialyzer system as well as connection with a detection apparatus that can perform optical detection of blood flowing through the cuvette element. Steuer et al. teach that the cuvette/conduit incorporates a transducer means, responsive to pressure pulsations to dampen movements/pressure transducer. The optical attachment position is axially displaced from the movable membrane (Fig 8 – 10 and the descriptions thereof), providing space for membrane movement. Response to Arguments Applicant’s arguments with respect to claim(s) 15 – 18, 20 – 27, 29, and 30 have been considered but are moot because the new ground of rejection does not rely on any reference applied in the prior rejection of record for any teaching or matter specifically challenged in the argument. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. Karkar et al. (USPN 4,745,279) teach an additional extracorporeal attachable blood sensing arrangement. Any inquiry concerning this communication or earlier communications from the examiner should be directed to ERIC FRANK WINAKUR whose telephone number is (571)272-4736. The examiner can normally be reached Mon-Fri 9 am - 6 pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jackie Cheng can be reached at 571-272-5596. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ERIC F WINAKUR/Primary Examiner, Art Unit 3791
Read full office action

Prosecution Timeline

Show 1 earlier event
Sep 27, 2024
Non-Final Rejection mailed — §102, §112
Dec 23, 2024
Response Filed
Apr 08, 2025
Final Rejection mailed — §102, §112
Jul 08, 2025
Request for Continued Examination
Jul 11, 2025
Response after Non-Final Action
Sep 24, 2025
Non-Final Rejection mailed — §102, §112
Jan 22, 2026
Response Filed
Jan 22, 2026
Response after Non-Final Action

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12635917
REMOTE BLOOD VOLUME MONITOR
2y 8m to grant Granted May 26, 2026
Patent 12635938
MONITORING FOR SLEEP APNEA USING NON-CONTACT MONITORING SYSTEM AND PULSE OXIMETRY SYSTEM
2y 8m to grant Granted May 26, 2026
Patent 12635896
Bio-impedance Measurement Device and Bio-impedance Measurement Method
2y 1m to grant Granted May 26, 2026
Patent 12629068
DETECTING AND CORRECTING FOR INTERFERENCE IN AN ANALYTE MONITORING SYSTEM
2y 7m to grant Granted May 19, 2026
Patent 12629073
SYSTEM AND METHOD FOR PROVIDING NEUROFEEDBACK FROM STEADY-STATE VISUAL EVOKED POTENTIALS TO TARGET AFFECT-BIASED ATTENTION FOR TREATING THERAPEUTIC OUTCOMES SUCH AS ANXIETY AND DEPRESSION
2y 8m to grant Granted May 19, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
79%
Grant Probability
93%
With Interview (+14.0%)
3y 2m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 1036 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month